Can I take Mounjaro with amlodipine?

Is there a known interaction between Mounjaro and amlodipine?

The short answer is no — not a pharmacokinetic one that appears in the Mounjaro SmPC or the BNF entry for tirzepatide. Amlodipine is a calcium-channel blocker prescribed most often for high blood pressure and chest pain. Tirzepatide, the active ingredient in Mounjaro, works on GIP and GLP-1 receptors in an entirely different pathway. The two medicines do not compete for the same metabolic routes in the way that, say, some statins and anticoagulants can.

What does exist is an indirect, additive effect. Mounjaro can modestly lower blood pressure as weight falls and as its own pharmacology takes effect. Amlodipine does the same, by relaxing blood-vessel walls. Together, the reduction may be more pronounced than either achieves alone. For most people that is not a problem — it may even be welcome. For someone whose blood pressure is already well-controlled and sitting at the lower end of normal, a further drop could cause light-headedness or dizziness, particularly when standing up quickly.

A simple checking habit: take your blood pressure at home (many pharmacies have walk-in monitors, and they take under a minute) during the first few weeks of Mounjaro treatment. If your readings are noticeably lower than your usual range, let your GP or prescriber know. That one step catches the vast majority of cases where an adjustment to your amlodipine dose might be sensible.

For a broader look at how Mounjaro interacts with other common medicines and supplements, the general Mounjaro interactions guide covers the landscape in more detail.

Does Mounjaro's effect on gastric emptying matter for amlodipine?

Mounjaro slows the rate at which the stomach empties its contents into the small intestine. This is part of how it reduces appetite and blunts blood-sugar spikes after meals. For most medicines it has little practical consequence, because amlodipine in particular is absorbed steadily over many hours regardless of food timing, and small delays in gastric transit are unlikely to change how much reaches your bloodstream overall.

The SmPC does flag gastric-emptying effects as a theoretical consideration for co-administered oral medicines. In practice, prescribers treat this as a reason to be aware rather than a reason to avoid the combination. Your prescriber may ask whether your amlodipine dose has been stable, and whether you tend to take it at a fixed time relative to meals. If you take it first thing in the morning without food, the interaction with gastric emptying is even less relevant, since your stomach is empty anyway.

People managing more complex blood-pressure regimens (for instance, combining amlodipine with an ACE inhibitor or ARB) may find the clinical picture warrants closer monitoring. If you have chronic kidney disease alongside hypertension, that adds another layer your prescriber will want to think through carefully.

What should you tell your prescriber before starting Mounjaro?

Every nume consultation requires a full medication disclosure. This is not a formality. A GPhC-registered Independent Prescriber reads through your answers personally, checking for combinations that need monitoring or that change the clinical calculus. Amlodipine should be listed clearly, along with the dose you currently take and how long you have been stable on it.

Your prescriber will also want to know your most recent blood-pressure readings if you have them, whether your hypertension has been straightforward to manage or has needed several adjustments, and whether you experience any dizziness when you stand up already. That last point matters because orthostatic hypotension (a transient pressure drop on standing) is easier to manage if everyone knows it is a possibility before treatment starts.

If you are curious about how eligibility is assessed more broadly, the BMI and Mounjaro eligibility page explains the clinical thresholds in full. And for people weighing up what Mounjaro treatment involves from the beginning, the Mounjaro overview is a good starting point.

For questions about other medicines alongside tirzepatide, our prescribers also field frequent queries about things like fluoxetine and Mounjaro and berberine with Mounjaro, the interaction picture differs meaningfully across these combinations, which is exactly why individual clinical review matters.

How does this affect your decision to start treatment?

Taking amlodipine does not rule out Mounjaro. For most people with hypertension using a stable amlodipine prescription, it is one of many medicines that a prescriber simply factors in, monitored, not barred. The NHS patient information for tirzepatide lists the categories of medicines to mention to your prescriber, and blood-pressure medicines feature there, because transparency makes prescribing safer rather than because the combination is routinely problematic.

Costs and what is included in private treatment are worth understanding before you commit; you can find a plain breakdown on the Mounjaro pricing page. If you decide to move forward, nume's process is straightforward: a free consultation, same-day review by a named prescriber, and, once clinically approved, next-working-day delivery. Our clinical team reviews every consultation personally. No algorithms, no shortcuts.

Ready to see whether Mounjaro is right for you? Start your free consultation and let our prescribers assess your full picture, amlodipine and all.